SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.

Andere talen Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Aandelen

688366

CNE100003NX4

slotkoers Shanghai S.E. Andere beurzen 00:00:00 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
92,45 ^CNY	+0,84%		-0,05%	-14,63%

29/04	Shanghai Haohai Biological Technology Co. rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
11/03	Winst Shanghai Haohai's 2023 stijgt op hogere omzet; aandelen stijgen 5%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shanghai Haohai's 2023 Profit Rises on Higher Revenue; Shares Rise 5%	11/03
Shanghai Haohai Biological Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024	08/03
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Shanghai Haohai Biological Forecasts Up to 138% Boost in 2023 Profit	29/01
Shanghai Haohai Biological Technology Co., Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023	29/01
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	03/01
Shanghai Haohai Biological Technology Co., Ltd. Announces Resignation of Guo Yongqing as Independent Non-Executive Director, Chairman of Audit Committee, Member of Remuneration and Appraisal Committee and Member of Nomination Committee	01/12
Haohai Biological Technology's Q3 Profit Rises 34%; Hong Kong Shares Jump 5%	26-10-23
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.	10-10-23
Shanghai Haohai Biological Technology Co., Ltd. commences an Equity Buyback Plan for 1,538,461 shares, representing 0.9% for CNY 200 million, under the auhtorization approved on September 15, 2023.	27-09-23
Shanghai Haohai Biological Technology to See Rise in January-September Profit	25-09-23
Shanghai Haohai Biological Technology Co., Ltd. Provides Unaudited Consolidated Financial Guidance for the Nine Months Ended 30 September 2023	25-09-23
Shanghai Haohai Biological Technology's Profit Surges 188.9% in H1; Shares Up 3%	18-08-23
Shanghai Haohai Biological Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17-08-23
Shanghai Haohai Biological Technology Co., Ltd. authorizes a Buyback Plan.	17-08-23
Shanghai Haohai Biological to Buy Remaining Stake in Medical Aesthetics, Cosmetology Business	01-08-23
Shanghai Haohai Biological Technology Co., Ltd. entered into the equity transfer agreement to acquire 36.3636% stake in OHMK Medical Technology Co., Ltd. from Tianjin Huacan Enterprise Management Consulting Partnership, Shanghai Ermei Enterprise Management Consulting Partnership, Yuan Yibing, Lian Songyong and Chen Guangfei for approximately CNY 150 million.	01-08-23
Shanghai Haohai Biological Technology’s H1 Profit to See Up to 210% Boost	21-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Shanghai Haohai Biological Technology Co., Ltd. Shanghai S.E.

Aandelen

688366

CNE100003NX4

Andere talen

Filters